Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Oncogene - 30(2011), 5 vom: 3. Feb., Seite 561-575 |
Beteiligte Personen: |
Dunn, E F [VerfasserIn] |
---|
Umfang: |
14 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1857980778 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1857980778 | ||
003 | DE-627 | ||
005 | 20230712062633.0 | ||
007 | tu | ||
008 | 110207s2011 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw110203_1 |
035 | |a (DE-627)OLC1857980778 | ||
035 | |a (DE-599)GBVOLC1857980778 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 610 |
100 | 1 | |a Dunn, E F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab |
264 | 1 | |c 2011 | |
300 | |a 14 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Iida, M |4 oth | |
700 | 1 | |a Myers, R A |4 oth | |
700 | 1 | |a Campbell, D A |4 oth | |
700 | 1 | |a Hintz, K A |4 oth | |
700 | 1 | |a Armstrong, E A |4 oth | |
700 | 1 | |a Li, C |4 oth | |
700 | 1 | |a Wheeler, D L |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Oncogene |d New York, NY : Springer Nature, 1987 |g 30(2011), 5 vom: 3. Feb., Seite 561-575 |w (DE-627)168132338 |w (DE-600)639046-8 |w (DE-576)015929388 |x 0950-9232 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2011 |g number:5 |g day:3 |g month:02 |g pages:561-575 |g extent:14 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_2219 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4305 | ||
951 | |a AR | ||
952 | |d 30 |j 2011 |e 5 |b 3 |c 2 |h 561-575 |g 14 |